Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,502 | Dovepress* | 9,428+ | 293 | 9,721 | |
| PubMed Central* | 1,074 | 164 | 1,238 | ||
| Totals | 10,502 | 457 | 10,959 | ||
| *Since 2 June 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar